Latest News

(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Silke Gillessen presented an update from the International Germ Cell Cancer Collaborative Group (IGCCCG). As clinicians […]

(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, Dr. Yohann Loriot presented a clinical oncologist’s perspective on the need for treatment de-escalation in advanced disease.

(Urotoday.com)  The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, Dr. Robert Hamilton presented on the management of early-stage (CSI) seminoma, focussing on existing guidelines including the role of surveillance, prognostic factors, radiotherapy, […]

(Urotoday.com)  The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Craig Nichols presented an update on the SWOG S1823 study, a prospective observational cohort study […]

(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, Dr. Andrew Stephenson presented on the management of early-stage clinical stage I (CSI) seminoma.

(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12th focused on testis cancer. In this session, Dr. Andrew Stephenson presented on the management of early-stage clinical stage I (CSI) seminoma.

(Urotoday.com) The penile cancer session at the inaugural virtual summit of the Global Society of Rare Genitourinary Tumors (GSRGT) included a presentation of conservative strategies for lymph node management, including minimally invasive staging of the groin, by Dr. Oscar Brouwer from The Netherlands Cancer Institute. Dr. Brouwer notes that penile cancer survival is highly dependent on […]

(Urotoday.com) The penile cancer session at the inaugural virtual summit of the Global Society of Rare Genitourinary Tumors (GSRGT) included a presentation of conservative therapy for primary penile cancer from Dr. Peter Johnstone from the Moffitt Cancer Center. Dr. Johnstone notes that there are important tenants of penile cancer therapy, including (i) centralization of care to […]

(Urotoday.com) The first Global Society of Rare Genitourinary Tumors (GSRGT) virtual summit on penile cancer featured a keynote lecture by Dr. Philippe Spiess from the Moffitt Cancer Center discussing updates in the molecular basis of penile cancer. It is important to note that in 2018, there were an estimated 2,080 new cases of penile cancer diagnosed […]

San Francisco, California (UroToday.com) — EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of BAVENCIO® (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with […]